4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001209191-20-063780
Chief Executive Officer sold 1 shares at $25.00 ($25)
- Chief Executive Officer acquired 1 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Ballal Rahul D. · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-12-14 | Exercise or conversion : show line 1 in the form | +1 | $3.15 | $3 | 1 | D |
| 2020-12-14 | Sale : show line 2 in the form | −1 | $25.00 | $25 | 0 | D |
| Open-market sales · 1 sh · avg $25.00 · $25 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-12-14 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −1 | 268,998 | D |
Loading xslF345X03/doc4.xml…